As an incretin hormone, GLP-1 plays a fundamental role in glucose homeostasis by stimulating glucose-dependent insulin secretion from pancreatic beta-cells and inhibiting glucagon release, which is the primary mechanism by which GLP-1RAs treat type 2 diabetes [127,128]. This evidence concerns the gene INS and type 2 diabetes mellitus.